Brought to you by:
New analysis points to lack of vascular surgical voices in news coverage of vascular disease
A new study set to be aired at the 2024 Society for Clinical Vascular Surgery (SCVS) annual meeting (March 16–20) in Scottsdale, Arizona, sheds a statistical spotlight on the state of the specialty’s reach into the mainstream consciousness. A team…
IVUS use in claudicants not associated with improved outcomes, claims data show
The use of intravascular ultrasound (IVUS) for the treatment of claudication doubled over a four-year period but there was “no clear relationship between IVUS use and improved patient outcomes,” a recently presented retrospective analysis of claims data showed. Researchers found…
The top 10 most popular Vascular Specialist stories of January 2024
In January, the most read stories from Vascular Specialist include a U.S. Aortic Research Consortium analysis of F/BEVAR preoperative risk factors in AAAs/TAAAs; a reflection on lessons learnt one year on from BEST-CLI; Southern Vascular’s election of its first female…
First patient treated in ZFEN+ fenestrated endovascular graft study
Cook Medical has announced the first patient treated in the clinical study of the Zenith Fenestrated+ endovascular graft (ZFEN+) in the U.S. The procedure was performed on Jan. 29, 2024, at the University of Texas Health (UTHealth) in Houston, Texas, by…
Why should SVS members respond when they receive an invitation to complete an RUC survey?
The Society for Vascular Surgery (SVS) is an active participant in the American Medical Association (AMA)/ Specialty Society Relative Value Scale Update Committee (RUC) process. A very important component of the RUC process is the RUC survey. The rules related…
SVS receives CMSS grant to advance diagnostic excellence
The Society for Vascular Surgery (SVS) has received a $100,000 grant from the Council of Medical Specialty Societies (CMSS) to promote diagnostic excellence across the medical field. The CMSS, a coalition of 53 specialty societies representing over 800,000 physicians, has…
Enrollment complete in APEX-AV study of mechanical aspiration system for acute PE
Patient enrollment is now complete in the APEX-AV trial evaluating the safety and efficacy of the AlphaVac F1885 (AngioDynamics) multipurpose mechanical aspiration system for the treatment of acute intermediate-risk pulmonary embolism (PE). APEX-AV is a single-arm investigational device exemption (IDE)…
Researchers report 30-day outcome data for pair of investigational carotid stenting systems
Thirty-day results from two trials assessing the performance of investigational carotid artery stenting systems—the Neuroguard and the CGuard—were recently presented at VIVA 2023. Stenting with the CGuard embolic protection carotid stent system (InspireMD) in patients with carotid artery stenosis and…
For Diabetes Month, diabetes resources for SVS members, patients
November is National Diabetes Month. Because SVS members treat patients with the condition—and its complications—the Society has numerous educational resources available. “Diabetes and Vascular Disease” is one of nearly 10 patient education fliers produced by the SVS Foundation as part…
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and death that helped sway the US FDA
Data from a patient-level meta-analysis—a factor in the US Food and Drug Administration’s (FDA) recent change of position on the use of paclitaxel-coated devices to treat peripheral arterial disease (PAD)—have been made public for the first time at TCT 2023…